| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/BBRC.1998.9130 |
| P8608 | Fatcat ID | release_6wgt7sxqdbbg3m5naktoaldkmi |
| P698 | PubMed publication ID | 9705871 |
| P2093 | author name string | Rossi A | |
| Melino G | |||
| Catani MV | |||
| Bernassola F | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 275-278 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Inhibition of clotting factor XIII activity by nitric oxide | |
| P478 | volume | 249 |
| Q38739380 | Arterial ageing: from endothelial dysfunction to vascular calcification. |
| Q33991767 | Biological chemistry and clinical potential of S-nitrosothiols |
| Q33668687 | Blood coagulation factor XIII: structure and function |
| Q93340527 | Blood coagulation response and bacterial adhesion to biomimetic polyurethane biomaterials prepared with surface texturing and nitric oxide release |
| Q28256613 | Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria |
| Q37810103 | Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria |
| Q34034199 | Evidence for S-nitrosothiol-dependent changes in fibrinogen that do not involve transnitrosation or thiolation. |
| Q36165992 | Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties |
| Q85378017 | Free-radical oxidation of plasma fibrin-stabilizing factor |
| Q35010231 | Gene expression in Peyronie's disease |
| Q43635660 | Inactivation of multiple targets by nitric oxide in CD95-triggered apoptosis. |
| Q34463493 | Is nitric oxide overproduction the target of choice for the management of septic shock? |
| Q54019589 | Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression. |
| Q30152638 | Modification of the catalytic subunit of plasma fibrin-stabilizing factor under induced oxidation |
| Q34540331 | Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals |
| Q38259274 | New perspectives on the thrombotic complications of haemolysis |
| Q35085306 | Nitric oxide and S-nitrosothiols in human blood. |
| Q45764233 | Nitric oxide: a challenge to chiropractic |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q47249169 | Oxidation of proteins: is it a programmed process? |
| Q36780187 | Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria |
| Q35743096 | Regulation of the apoptosis-necrosis switch |
| Q33834230 | Regulation of transglutaminases by nitric oxide |
| Q44523807 | Reversible inhibition of the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols |
| Q34391779 | S-nitrosoglutathione acts as a small molecule modulator of human fibrin clot architecture |
| Q37710137 | S-nitrosothiols as selective antithrombotic agents - possible mechanisms |
| Q58820736 | Strain-dependent susceptibility for hypertension in mice resides in the natural killer gene complex |
| Q33814380 | The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications |
| Q34836065 | The role of reactive oxygen species in microvascular remodeling |
| Q26853483 | Thrombosis in paroxysmal nocturnal hemoglobinuria |
| Q24534936 | Transglutaminases: nature's biological glues |
Search more.